SUPPLY CHAIN
Historically , clinical trials have been plagued by a huge issue - a lack of diversity among participants . This is problematic , as how can you ensure a medicine or vaccine you ' re releasing will be effective across the whole population , if it ' s only been tested on a narrow demographic ?
While the medical community has talked about this issue for years , COVID-19 finally spurred people into action . Working with
“ I take a lot of pride in the fact that there ' s a lot of outreach in the community ”
SALLY EMBREY VP OF PUBLIC HEALTH AND MEDICAL TECHNOLOGIES AT DATAROBOT vaccine distributors and the Department of Health and Human Services ( HHS ), scientists at DataRobot developed a strategy to overcome this . " We were looking for opportunities that would help speed up the clinical trials " explains Sally Embrey , VP of Public Health and Health Technologies . " At the beginning of the pandemic we reallocated 50 % of our R & D resources to examine COVID-19 as a data science problem .
healthcareglobal . com 117